PAR 4.65% 22.5¢ paradigm biopharmaceuticals limited..

WANTED PARA-008 Trial Participants, page-97

  1. 2,150 Posts.
    lightbulb Created with Sketch. 581
    Because, as others have pointed out, Paradigm investor relations don’t respond to questions. And I’m not saying questions like:

    ”why didn’t you apply for fast track at IND like you said you would at the R&D day”

    and I can bring up a lot of q’s that would make you uncomfortable. They just don’t answer.

    And as for Mozz suggesting an eight study to bring home a DMOAD label - well that was why we are all sitting here for another five years with the current program.

    They can’t execute - and the sooner we get past the excuses/apologists/hero worship and hold them to account - the better.
    Last edited by Gan_Gans: 25/08/21
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.010(4.65%)
Mkt cap ! $78.73M
Open High Low Value Volume
22.0¢ 23.5¢ 21.5¢ $288.5K 1.279M

Buyers (Bids)

No. Vol. Price($)
6 130626 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.0¢ 60000 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.